China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of eculizumab therapy in the acute-staged severe AQP-4 IgG antibody positive optic neuritis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133029
Registration Time: 2026/09/21
Type: Interventional study
Primary Sponsor: Eye Hospital, Wenzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342073
Published by HT Digital Content Services with permission from Health Daily Digest....